Spotlight Presentation: An AI-Driven Approach to CHO Biologics Production: From Genetic Design to Bioprocess Optimization
01 Sept 2026
Cell Line Development
Upstream Development
Downstream Processing & Purification
Formulation & Stability
Quality Control & Characterization
)
As biologics pipelines become more complex, developers are seeking cell line development solutions that offer both high performance and competitive timelines. Asimov’s CHO Edge System is an integrated AI and synthetic biology platform that routinely achieves high clonal titers across antibody modalities, from mAbs to complex bi- and multispecifics.
This presentation will introduce Asimov’s CHO Edge Platform with case studies spanning vector design, cell line development, and bioprocess optimization, and will also provide an overview of Asimov’s Rapid Pools platform, which generates high-throughput stable CHO expression pools to provide early, CLD-relevant expression and product quality data for better decision making.
Industry Expert
